GLUCAGON

N/A

Manufactured by Amphastar Pharmaceuticals, Inc.

13,146 FDA adverse event reports analyzed

Last updated: 2026-04-15

About GLUCAGON

GLUCAGON is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Amphastar Pharmaceuticals, Inc.. The most commonly reported adverse reactions for GLUCAGON include DRUG INEFFECTIVE, DYSPNOEA, ACUTE KIDNEY INJURY, HYPOTENSION, HYPOGLYCAEMIA. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for GLUCAGON.

Top Adverse Reactions

DRUG INEFFECTIVE362 reports
DYSPNOEA354 reports
ACUTE KIDNEY INJURY313 reports
HYPOTENSION286 reports
HYPOGLYCAEMIA268 reports
CONDITION AGGRAVATED244 reports
TOXICITY TO VARIOUS AGENTS230 reports
HAEMOPTYSIS214 reports
ANXIETY213 reports
NAUSEA212 reports
DEATH209 reports
PAIN IN EXTREMITY202 reports
BLOOD GLUCOSE DECREASED193 reports
BLOOD GLUCOSE INCREASED193 reports
VOMITING191 reports
ASTHMA190 reports
OFF LABEL USE188 reports
PNEUMONIA180 reports
HEADACHE175 reports
LUNG DISORDER172 reports
WHEEZING172 reports
RENAL FAILURE171 reports
PULMONARY FIBROSIS170 reports
HYPOXIA168 reports
INTENTIONAL OVERDOSE168 reports
OBSTRUCTIVE AIRWAYS DISORDER168 reports
PULMONARY ALVEOLAR HAEMORRHAGE168 reports
THERAPEUTIC PRODUCT EFFECT INCOMPLETE168 reports
NEURITIS167 reports
NEUROLOGICAL SYMPTOM166 reports
PULMONARY VASCULITIS166 reports
VASCULITIS166 reports
RESPIRATORY SYMPTOM163 reports
HYPOTHYROIDISM162 reports
BRADYCARDIA160 reports
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES154 reports
CHRONIC KIDNEY DISEASE153 reports
PRODUCTIVE COUGH150 reports
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION149 reports
FULL BLOOD COUNT ABNORMAL147 reports
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS144 reports
FATIGUE138 reports
DIARRHOEA137 reports
DIZZINESS130 reports
PULMONARY EMBOLISM130 reports
OVERDOSE129 reports
SEPSIS127 reports
THROMBOSIS121 reports
MALAISE116 reports
ARTERIOSCLEROSIS113 reports
CARDIAC ARREST112 reports
ARTERIOSCLEROSIS CORONARY ARTERY110 reports
PYREXIA110 reports
FORCED EXPIRATORY VOLUME DECREASED109 reports
NORMOCHROMIC NORMOCYTIC ANAEMIA109 reports
COUGH108 reports
CONJUNCTIVITIS ALLERGIC107 reports
NODULE106 reports
DUST ALLERGY104 reports
MITE ALLERGY104 reports
MYCOTIC ALLERGY104 reports
PAIN104 reports
TOTAL LUNG CAPACITY ABNORMAL104 reports
FALL103 reports
SPIROMETRY ABNORMAL100 reports
ASTHENIA98 reports
CARDIOGENIC SHOCK94 reports
DRUG INTERACTION90 reports
LOSS OF CONSCIOUSNESS90 reports
RESPIRATORY FAILURE90 reports
ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE89 reports
END STAGE RENAL DISEASE82 reports
NASAL DISCOMFORT80 reports
SUICIDE ATTEMPT80 reports
THROMBOCYTOPENIA78 reports
RASH74 reports
URINARY TRACT INFECTION74 reports
PLEURAL EFFUSION72 reports
PRODUCT DOSE OMISSION ISSUE72 reports
CARDIAC FAILURE CONGESTIVE71 reports
NO ADVERSE EVENT70 reports
ABDOMINAL PAIN68 reports
LACTIC ACIDOSIS65 reports
SEIZURE65 reports
HYPERGLYCAEMIA64 reports
RENAL IMPAIRMENT63 reports
WEIGHT DECREASED63 reports
SHOCK62 reports
DEHYDRATION60 reports
ANAEMIA58 reports
INCORRECT DOSE ADMINISTERED58 reports
CHEST PAIN57 reports
SYNCOPE57 reports
COMA56 reports
METABOLIC ACIDOSIS55 reports
SOMNOLENCE55 reports
RHINALGIA54 reports
CAPILLARITIS53 reports
CARDIOMEGALY53 reports
DECREASED APPETITE52 reports

Report Outcomes

Out of 3,941 classified reports for GLUCAGON:

Serious 78.2%Non-Serious 21.8%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female1,865 (52.0%)
Male1,717 (47.9%)
Unknown4 (0.1%)

Reports by Age

Age 65199 reports
Age 7670 reports
Age 6269 reports
Age 5567 reports
Age 5963 reports
Age 6861 reports
Age 5459 reports
Age 5256 reports
Age 5755 reports
Age 6455 reports
Age 5854 reports
Age 6154 reports
Age 7554 reports
Age 6053 reports
Age 5152 reports
Age 6752 reports
Age 7251 reports
Age 6349 reports
Age 6949 reports
Age 7048 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with GLUCAGON?

This profile reflects 13,146 FDA FAERS reports that mention GLUCAGON. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for GLUCAGON?

Frequently reported terms in FAERS include DRUG INEFFECTIVE, DYSPNOEA, ACUTE KIDNEY INJURY, HYPOTENSION, HYPOGLYCAEMIA, CONDITION AGGRAVATED. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures GLUCAGON?

Labeling and FAERS entries often list Amphastar Pharmaceuticals, Inc. in connection with GLUCAGON. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.